BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 11359945)

  • 41. Overexpression of cyclin E and cyclin-dependent kinase inhibitor (p27Kip1): effect on cell cycle regulation in HeLa cells.
    Kwon TK; Nordin AA
    Biochem Biophys Res Commun; 1997 Sep; 238(2):534-8. PubMed ID: 9299546
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Transforming growth factor beta-induced activation of cyclin E-cdk2 kinase and down-regulation of p27Kip1 in C3H 10T1/2 mouse fibroblasts.
    Ravitz MJ; Yan S; Herr KD; Wenner CE
    Cancer Res; 1995 Apr; 55(7):1413-6. PubMed ID: 7882344
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cytoplasmic displacement of cyclin E-cdk2 inhibitors p21Cip1 and p27Kip1 in anchorage-independent cells.
    Orend G; Hunter T; Ruoslahti E
    Oncogene; 1998 May; 16(20):2575-83. PubMed ID: 9632134
    [TBL] [Abstract][Full Text] [Related]  

  • 44. End-stage differentiation of neutrophil granulocytes in vivo is accompanied by up-regulation of p27kip1 and down-regulation of CDK2, CDK4, and CDK6.
    Klausen P; Bjerregaard MD; Borregaard N; Cowland JB
    J Leukoc Biol; 2004 Mar; 75(3):569-78. PubMed ID: 14694185
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Growth arrest by the cyclin-dependent kinase inhibitor p27Kip1 is abrogated by c-Myc.
    Vlach J; Hennecke S; Alevizopoulos K; Conti D; Amati B
    EMBO J; 1996 Dec; 15(23):6595-604. PubMed ID: 8978686
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The cdk2 kinase is required for the G1-to-S transition in mammalian cells.
    Tsai LH; Lees E; Faha B; Harlow E; Riabowol K
    Oncogene; 1993 Jun; 8(6):1593-602. PubMed ID: 8502482
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Investigation of the role of G1/S cell cycle mediators in cellular senescence.
    Afshari CA; Vojta PJ; Annab LA; Futreal PA; Willard TB; Barrett JC
    Exp Cell Res; 1993 Dec; 209(2):231-7. PubMed ID: 8262140
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inhibition of G1-phase arrest induced by ionizing radiation in hematopoietic cells by overexpression of genes involved in the G1/S-phase transition.
    Epperly M; Berry L; Halloran A; Greenberger JS
    Radiat Res; 1995 Sep; 143(3):245-54. PubMed ID: 7652161
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Lats2, a putative tumor suppressor, inhibits G1/S transition.
    Li Y; Pei J; Xia H; Ke H; Wang H; Tao W
    Oncogene; 2003 Jul; 22(28):4398-405. PubMed ID: 12853976
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dynamics of the cell cycle engine: Cdk2-kinase and the transition into mitosis.
    Kaern M; Hunding A
    J Theor Biol; 1998 Jul; 193(1):47-57. PubMed ID: 9689942
    [TBL] [Abstract][Full Text] [Related]  

  • 51. High expression of cyclin E and G1 CDK and loss of function of p57KIP2 are involved in proliferation of malignant sporadic adrenocortical tumors.
    Bourcigaux N; Gaston V; LogiƩ A; Bertagna X; Le Bouc Y; Gicquel C
    J Clin Endocrinol Metab; 2000 Jan; 85(1):322-30. PubMed ID: 10634406
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Expression of G1 cyclins and cyclin-dependent kinase-2 activity during terminal differentiation of cultured human trophoblast.
    McKenzie PP; Foster JS; House S; Bukovsky A; Caudle MR; Wimalasena J
    Biol Reprod; 1998 May; 58(5):1283-9. PubMed ID: 9603265
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The role of p55CDC in cell cycle control and mammalian cell proliferation, differentiation, and apoptosis.
    Lin M; Chang JK; Shankar D; Sakamoto KM
    Exp Mol Pathol; 2003 Apr; 74(2):123-8. PubMed ID: 12710943
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Differential regulation of the major cyclin-dependent kinases, cdk2 and cdc2, during cell cycle progression in human lymphocytes exposed to heptachlor.
    Chuang LF; Rought SE; Chuang RY
    In Vivo; 1999; 13(6):455-61. PubMed ID: 10757037
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Rho-associated kinases play an essential role in cardiac morphogenesis and cardiomyocyte proliferation.
    Zhao Z; Rivkees SA
    Dev Dyn; 2003 Jan; 226(1):24-32. PubMed ID: 12508221
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cdk1: the dominant sibling of Cdk2.
    Bashir T; Pagano M
    Nat Cell Biol; 2005 Aug; 7(8):779-81. PubMed ID: 16056272
    [No Abstract]   [Full Text] [Related]  

  • 57. Cyclin E and cyclin A as candidates for the restriction point protein.
    Dou QP; Levin AH; Zhao S; Pardee AB
    Cancer Res; 1993 Apr; 53(7):1493-7. PubMed ID: 8384078
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cyclin E2: a novel CDK2 partner in the late G1 and S phases of the mammalian cell cycle.
    Lauper N; Beck AR; Cariou S; Richman L; Hofmann K; Reith W; Slingerland JM; Amati B
    Oncogene; 1998 Nov; 17(20):2637-43. PubMed ID: 9840927
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cell cycle regulatory protein expression in fresh acute myeloid leukemia cells and after drug exposure.
    Radosevic N; Delmer A; Tang R; Marie JP; Ajchenbaum-Cymbalista F
    Leukemia; 2001 Apr; 15(4):559-66. PubMed ID: 11368357
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hypoxia inhibits G1/S transition through regulation of p27 expression.
    Gardner LB; Li Q; Park MS; Flanagan WM; Semenza GL; Dang CV
    J Biol Chem; 2001 Mar; 276(11):7919-26. PubMed ID: 11112789
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.